EIF2A and amyotrophic lateral sclerosis: Salubrinal and guanabenz, two eiF2α phosphatase inhibitors, protected against MN degeneration in ALS mice (Saxena et al., 2009;Wang et al., 2014), although one study reported that guanabenz accelerated disease progression in an ALS model (Vieira et al., 2015).